Lower riskMedical device recall · FDA · Published August 24, 2021
Bard Peripheral Vascular Inc: Misbranded Bone Marrow Biopsy Trays Recalled
Bard recalls 10 units of misbranded bone marrow biopsy trays and needles due to incorrect labeling. Affected items may not be safe for medical use without proper identification.
“Bard Peripheral Vascular Inc: Misbranded Bone Marrow Biopsy Trays Recalled.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61906-bard-peripheral-vascular-inc-misbranded-bone-marrow-biopsy-trays-recalled. Based on FDA recall #Z-0153-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0153-2022%22&limit=1).
Bard Peripheral Vascular Inc recalled Catalog # BEK4511 bone marrow biopsy and aspiration trays due to misbranded products shipped to customers, according to the FDA. The Food and Drug Administration announced the Class II recall on Aug. 24, 2021.
How to tell if you have it
Brand: Bard
Catalog # BEK4511
UPC 50885403057265
Lot No.: 0001379055
Sold in CA, GA, HI, IL, IN, LA, MO, MS, NC, OH, PA, PR, TX, UT, VA, and WA
The hazard
The recall involves misbranded products shipped to customers. The FDA said the hazard is due to this misbranding.
Context
GovInfoNow's records show Bard Peripheral Vascular Inc has 40 other recalls on record since Sept. 22, 2017. Other recent recalls of similar products include Bard Breast Biopsy System May Cause Procedure Interruptions (Aug. 20, 2026) and Bard Safe-T-Centesis 6 Fr Catheter Drainage Tray Recall: Erroneous Safety Indicator Risk (Nov. 6, 2025).
How to tell if you have this one
Check for the catalog number BEK4511 and the specific model of bone marrow biopsy tray and needles. These items were sold by Bard Peripheral Vascular Inc.
Brand
Bard
Product
Catalog # BEK4511, Qty: 10, Ecomomy Jamshidi Bone Marrow Biopsy and Aspiration Tray, 11 G X 4"Biopsy/Aspiration needle
Category
Medical device
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Terminated
Distribution
U.S. Distribution: CA, GA,HI, IL, IN, LA, MO, MS, NC, OH, PA, PR, TX, UT, VA, and WA. OUS: None
Recall number
Product, codes & lots
Z-0153-2022
Catalog # BEK4511, Qty: 10, Ecomomy Jamshidi Bone Marrow Biopsy and Aspiration Tray, 11 G X 4"Biopsy/Aspiration needle, 15 G Aspiration Needle (Adjustable Length 15/16" -1-7/8") (24mm-48mm) sterile, For Single Use Only, RX only. Exp. Date Lidocaine Vendor lot. CareFusion. Original Jamshidi" Bone Marrow Biopsy/Aspiration Needle: - also referred to as Jamshidi needle Intended use for the posterior iliac crest biopsy technique; Cat No.: BEK4511; Lot /Serial No.: 0001379055; UDI # (01)50885403057265(17)211231(10)0001379055;
Z-0154-2022
Catalog # BEK3411, Ecomomy Jamshidi Bone Marrow Biopsy Tray, 11 G X 4"Biopsy/Aspiration needle, sterile, Qty: 10, Single Use Only, RX only. Exp. Date Lidocaine Vendor lot. CareFusion Intended use to aspirate marrow from either the sternum or the iliac crest. Intraosseous Infusion is recommended only in life-threatening emergencies where vascular access is critical and conventional forms of access are not available or are unobtainable.; Cat No.: BEK3411; Lot /Serial No.: 0001378561; UDI # BEK3411, Lot BEK3411, Lot BEK3411, Lot 0001378561; (01)50885403057258(17)211231(10)0001378561; Mfg. Date 08/19/2020; Exp. Date: 12/31/2021; Qty: 360
Based on the official FDA remedy
What to do — step by step
Check Product Label
Look for the catalog number BEK4511 on the product to confirm it is part of the recall.
Where it went and when
Where it was distributed
Distributed in 15 states and Puerto Rico.
Listed by the agency
Not listed
FDA distribution: “U.S. Distribution: CA, GA,HI, IL, IN, LA, MO, MS, NC, OH, PA, PR, TX, UT, VA, and WA. OUS: None” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: California, Georgia, Hawaii, Illinois, Indiana, Louisiana, Mississippi, Missouri, North Carolina, Ohio, Pennsylvania, Puerto Rico, Texas, Utah, Virginia, Washington.
Recall timeline
FDA terminated this recall 3.3 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0153-2022 (August 24, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0153-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.